{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:14:30Z","timestamp":1792610070010,"version":"4.5.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sleep disturbances, including excessive daytime sleepiness (EDS) and fragmented nocturnal sleep, are common in Parkinson's disease (PD) and significantly reduce quality of life. This pilot study evaluated the efficacy of a novel approach using blue light, delivered via dedicated glasses with integrated LED lights, to improve sleep and non-motor symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomised, placebo-controlled, single-blind pilot study with a 2-week light intervention. Participants were assessed at baseline, two weeks, and five weeks. The study was designed to evaluate between- and within-group changes. Participants were randomly allocated to receive blue light therapy (n\u2009=\u200915) or red light placebo (n\u2009=\u200915), delivered via LED-integrated glasses for one hour, twice daily, given for a 2-week period. Primary outcome was improvement in sleep quality, assessed via the Pittsburgh Sleep Quality Index. Secondary outcomes included diary-based sleep outcomes, excessive daytime sleepiness, mood, anxiety, and motor symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was a significant group\u2009\u00d7\u2009time effect with blue light therapy leading to better Pittsburgh Sleep Quality Index scores (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.021). Between-group analyses showed that at two weeks a trend toward significance was observed (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.065), while sleep quality significantly improved at five weeks compared to placebo (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.029) with a large effect size (0.896). Excessive sleepiness improved in the blue light group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001), with a reduction in clinically relevant sleepiness from 50.0% to 6.7% (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Blue light therapy delivered through dedicated glasses appeared to show an improvement in sleep quality and daytime sleepiness in individuals with PD. Blue light therapy offers a promising alternative to traditional light therapy utilising lower light intensities and eliminating the need for light boxes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x261468544","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:28:53Z","timestamp":1786004933000},"page":"1201-1210","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Blue light therapy delivered through light glasses improves sleep quality and daytime sleepiness in Parkinson's disease: A randomized trial"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9167-1624","authenticated-orcid":false,"given":"Katarzyna","family":"\u015ami\u0142owska","sequence":"first","affiliation":[{"name":"Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"},{"name":"Department of Neurology, 5th Regional Hospital, Sosnowiec, Poland"},{"name":"University of Silesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1972-2703","authenticated-orcid":false,"given":"Nienke M","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"},{"name":"University Medical Centre Groningen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-3337","authenticated-orcid":false,"given":"Bastiaan R","family":"Bloem","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-5158","authenticated-orcid":false,"given":"Daniel J","family":"van Wamelen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"},{"name":"Department of Neuroimaging, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK"},{"name":"King's College Hospital NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27802"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2017.05.032"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22643"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.65"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21586"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0640"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2013.844162"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2869.2000.00221.x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198309013090905"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007090"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.5192"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00741"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/07420520701420717"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21542"},{"key":"e_1_3_3_16_2","first-page":"63","article-title":"[The phototherapy of parkinsonism patients]","volume":"96","author":"Artemenko AR","year":"1996","unstructured":"Artemenko AR, Levin Ia I. [The phototherapy of parkinsonism patients]. Zh Nevrol Psikhiatr Im SS Korsakova 1996; 96: 63\u201366.","journal-title":"Zh Nevrol Psikhiatr Im SS Korsakova"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2011-0072"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1050-z"},{"key":"e_1_3_3_19_2","first-page":"1906271","article-title":"Blue light therapy glasses in Parkinson\u2019s disease: patients\u2019 experience","volume":"2019","author":"Smilowska K","year":"2019","unstructured":"Smilowska K, van Wamelen DJ, Schoutens AMC, et al. Blue light therapy glasses in Parkinson\u2019s disease: patients\u2019 experience. Parkinsons Dis 2019; 2019: 1906271.","journal-title":"Parkinsons Dis"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-019-01214-3"},{"key":"e_1_3_3_21_2","first-page":"267","article-title":"Bright light treatment: are we keeping our subjects in the dark?","volume":"13","author":"Dawson D","year":"1990","unstructured":"Dawson D, Campbell SS. Bright light treatment: are we keeping our subjects in the dark? Sleep 1990; 13: 267\u2013271.","journal-title":"Sleep"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.12.009"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40101-016-0091-9"},{"key":"e_1_3_3_24_2","article-title":"UK Parkinson\u2019s disease society brain bank clinical diagnostic criteria","volume":"55","author":"Hughes AJ","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE, et al. UK Parkinson\u2019s disease society brain bank clinical diagnostic criteria. J Neurol Neurosurg Psychiatry 1992; 55: e4.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/14.6.540"},{"key":"e_1_3_3_28_2","unstructured":"Cie S. 026\/E: 2018 CIE system for metrology of optical radiation for ipRGC-influenced responses to light. CIE Central Bureau: Vienna Austria 2018."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.12233"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2021.03.035"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040061"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21894"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27438"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261468544","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261468544","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261468544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:14:28Z","timestamp":1789136068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261468544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/1877718X261468544"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261468544","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}